Show simple item record

In silico Analysis of Sulpiride, Synthesis, Characterization and In vitro Studies of its Nanoparticle for the Treatment of Schizophrenia

dc.contributor.authorKokcu, Yagmur
dc.contributor.authorKaya, Zeynep
dc.contributor.authorAkyuz, Sevim
dc.contributor.authorÖzel, Ayşen
dc.contributor.authorKecel-Gunduz, Serda
dc.contributor.authorBıçak, Bilge
dc.contributor.authorBudama-Kilinc, Yasemin
dc.contributor.authorCakir-Koc, Rabia
dc.contributor.authorZorlu, Tolga
dc.date.accessioned2021-03-03T12:59:54Z
dc.date.available2021-03-03T12:59:54Z
dc.identifier.citationKecel-Gunduz S., Budama-Kilinc Y., Cakir-Koc R., Zorlu T., Bıçak B., Kokcu Y., Kaya Z., Özel A., Akyuz S., "In silico Analysis of Sulpiride, Synthesis, Characterization and In vitro Studies of its Nanoparticle for the Treatment of Schizophrenia", CURRENT COMPUTER-AIDED DRUG DESIGN, cilt.16, ss.104-121, 2020
dc.identifier.issn1573-4099
dc.identifier.othervv_1032021
dc.identifier.otherav_31574557-6fe5-414b-a7cf-8f9d4771f2d5
dc.identifier.urihttp://hdl.handle.net/20.500.12627/37584
dc.identifier.urihttps://doi.org/10.2174/1573409915666190627125643
dc.description.abstractBackground: Sulpiride, which has selective dopaminergic blocking activity, is a substituted benzamide antipsychotic drug playing a prominent role in the treatment of schizophrenia, which more selective and primarily blocks dopamine D2 and D3 receptor.
dc.language.isoeng
dc.subjectBilgisayar Bilimleri
dc.subjectKİMYA, TIP
dc.subjectKimya
dc.subjectTemel Bilimler (SCI)
dc.subjectBİLGİSAYAR BİLİMİ, İNTERDİSİPLİNER UYGULAMALAR
dc.subjectBilgisayar Bilimi
dc.subjectMühendislik, Bilişim ve Teknoloji (ENG)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectBilgisayar Grafiği
dc.subjectYaşam Bilimleri
dc.subjectBiyokimya
dc.subjectTemel Bilimler
dc.subjectMühendislik ve Teknoloji
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.titleIn silico Analysis of Sulpiride, Synthesis, Characterization and In vitro Studies of its Nanoparticle for the Treatment of Schizophrenia
dc.typeMakale
dc.relation.journalCURRENT COMPUTER-AIDED DRUG DESIGN
dc.contributor.departmentYıldız Teknik Üniversitesi , ,
dc.identifier.volume16
dc.identifier.startpage104
dc.identifier.endpage121
dc.contributor.firstauthorID2202447


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record